Page 6 - Maureen Horton News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Vicore Pharma Holding AB: Vicore to host R&D Day

GOTHENBURG, Sweden, March 4, 2022 /PRNewswire/ Vicore Pharma Holding AB (publ) ("Vicore"), a clinical-stage pharmaceutical company developing medicines targeting the angiotensin II type 2

United statesUnited kingdomVastra gotalands lanUniversity of southern californiaLos angelesCity ofVicore pharmaToby maherMaureen hortonGerry coghlanCarl johan dalsgaardUniversity college londonJohns hopkins universityNational cardiac dublinNational pulmonary hypertension physicians associationRegional health authority

Vicore Pharma Holding AB: Vicore starts dosing of first COVID-19 patients in the global phase 3 trial ATTRACT-3

Vicore Pharma Holding AB: Vicore starts dosing of first COVID-19 patients in the global phase 3 trial ATTRACT-3
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

South africaVastra gotalands lanCzech republicMaureen hortonCarl johan dalsgaardPrnewswire vicore pharma holdingJohns hopkins university schoolJohan dalsgaardசெக் குடியரசுஜான்ஸ் ஹாப்கின்ஸ் பல்கலைக்கழகம் பள்ளி

Vicore starts dosing of first COVID-19 patients in the global phase 3 trial ATTRACT-3

Vicore starts dosing of first COVID-19 patients in the global phase 3 trial ATTRACT-3
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

South africaVastra gotalands lanCzech republicMaureen hortonCarl johan dalsgaardPrnewswire vicore pharma holdingVicore pharma holdingJohns hopkins university schoolJohan dalsgaardPharma holdingசெக் குடியரசுஜான்ஸ் ஹாப்கின்ஸ் பல்கலைக்கழகம் பள்ளிபார்மா வைத்திருத்தல்

Vicore Pharma to host Key Opinion Leader webinar on C21 for the treatment of COVID-19

Share this article GOTHENBURG, Sweden, April 20, 2021 /PRNewswire/ Vicore Pharma Holding AB (publ) ( Vicore ), a pharmaceutical company developing innovative medicines for severe lung disorders such as idiopathic pulmonary fibrosis (IPF), today announced that it will host a key opinion leader (KOL) webinar on C21, the company s lead asset for the treatment of COVID-19, on Wednesday, April 28, 2021 at 14:00 CET (8 am EST). The event will feature a presentation by KOL Professor Maureen Horton, M.D., Johns Hopkins University School of Medicine, who will discuss the current treatment landscape and unmet medical needs in treating patients with COVID-19. Professor Horton will be available to answer questions following the conclusion of the event.

United statesVastra gotalands lanVicore pharmaMaureen hortonRohit battaCarl johan dalsgaardPrnewswire vicore pharma holdingVicore pharma holdingJohns hopkins university school of medicineInterstitial lung disease programJohns hopkins university schoolChief medical officerIdiopathic pulmonary fibrosisEnvironmental health engineeringCritical care medicineJohns hopkins hospital medical intensive care